HspE7

Heat shock protein 70–E7 fusion protein · Nventa Biopharmaceuticals Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HspE7, covering 2008-05-07 to 2008-05-07. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study to Test the Safety of HspE7 and Poly-ICLC Given in Patients With Cervical Intraepithelial Neoplasia [Phase 1]

See pricing